{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:38:45Z","timestamp":1792708725716,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00787-009-0042-7","type":"journal-article","created":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T11:53:20Z","timestamp":1246362800000},"page":"57-66","source":"Crossref","is-referenced-by-count":30,"title":["Atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia"],"prefix":"10.1007","volume":"19","author":[{"given":"Ferenc","family":"Martenyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay N.","family":"Zavadenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia B.","family":"Jarkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr A.","family":"Yarosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria O.","family":"Soldatenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid M.","family":"Bardenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Kozlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay G.","family":"Neznanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I.","family":"Maslova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey S.","family":"Petrukhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina K.","family":"Sukchotina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriy P.","family":"Zykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,1]]},"reference":[{"key":"42_CR1","first-page":"18","volume":"36","author":"RA Altschuler","year":"1973","unstructured":"Altschuler RA, Maschkovsky MD, Roshchina LF (1973) Sydnocarb is a new stimulant of the central nervous system. Farmacol Toxicol 36:18\u201323 (in Russian)","journal-title":"Farmacol Toxicol"},{"key":"42_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1542\/peds.86.2.184","volume":"86","author":"RA Barkley","year":"1990","unstructured":"Barkley RA, Murrary MB, Edelbrock CS, Robbins K (1990) Side effects of methylphenidate in children with attention-deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86:184\u2013192","journal-title":"Pediatrics"},{"key":"42_CR3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1749-6632.2002.tb04160.x","volume":"965","author":"V Bashkatova","year":"2002","unstructured":"Bashkatova V, Mathieu-Kia AM, Durand C, Penit-Soria J (2002) Neurochemical changes and neurotoxic effects of an acute treatment with sydnocarb, a novel psychostimulant: comparison with D-amphetamine. Ann N Y Acad Sci 965:180\u2013192","journal-title":"Ann N Y Acad Sci"},{"key":"42_CR4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/B:RUGE.0000033316.17087.62","volume":"40","author":"SA Borinskaya","year":"2004","unstructured":"Borinskaya SA, Kozhekbaeva ZhM, Gorbunova EV et al (2004) Analysis of the DRD4 gene polymorphism in populations of Russia and neighboring countries. Russ J Genet 40:679\u2013683 (in Russian)","journal-title":"Russ J Genet"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/A:1022602400621","volume":"26","author":"CK Conners","year":"1998","unstructured":"Conners CK, Sitarenios G, Parker JD, Epstein JN (1998) The revised Conners\u2019 Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26:257\u2013268","journal-title":"J Abnorm Child Psychol"},{"key":"42_CR6","unstructured":"Crichton A (1798) An Inquiry into the nature and origin of mental derangement: comprehending a concise system of physiology and pathology of the human mind and history of the passions and their effects. T. Cadell Jr. and W Davies, London (Reprinted by AMS Press, New York, 1976)"},{"key":"42_CR7","volume-title":"ADHD rating scale-IV: checklists, norms, and clinical interpretations","author":"GJ DuPaul","year":"1998","unstructured":"DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998) ADHD rating scale-IV: checklists, norms, and clinical interpretations. The Guilford Press, New York, NY"},{"key":"42_CR8","unstructured":"Faraone SV (2003) Understanding the effect size of ADHD medication: implications for clinical care. Medscape Psych Ment Health 28:2. www.medscape.com\/viewarticle\/461543"},{"key":"42_CR9","first-page":"104","volume":"2","author":"SV Faraone","year":"2003","unstructured":"Faraone SV, Sergeant J, Gillberg C, Biederman J (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104\u2013113","journal-title":"World Psychiatry"},{"key":"42_CR10","doi-asserted-by":"crossref","unstructured":"Guy W (1976) ECDEU assessment manual for psychopharmacology, revised. US Department of Health, Education, and Welfare, Bethesda, MD","DOI":"10.1037\/e591322011-001"},{"key":"42_CR11","volume-title":"On idiocy and imbecility","author":"W Ireland","year":"1877","unstructured":"Ireland W (1877) On idiocy and imbecility. JSA Churchill, London"},{"key":"42_CR12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","volume":"136","author":"J Kaufman","year":"1997","unstructured":"Kaufman J, Birmaher B, Brent D et al (1997) Schedule for affective disorders and schizophrenia for school-age children present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 136:980\u2013988","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.114.1.e1","volume":"114","author":"DK Kelsey","year":"2004","unstructured":"Kelsey DK, Sumner CR, Casat CD et al (2004) Once-daily atomoxetine treatment for children with attention-deficit\/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 114:e1\u2013e8","journal-title":"Pediatrics"},{"key":"42_CR14","first-page":"161","volume-title":"Teenagers of risk groups","author":"TV Kornilova","year":"2004","unstructured":"Kornilova TV, Grigorenko EL, Smirnov SD (2004) Teenagers of risk groups. Piter Publishers, Moscow-Saint Petersburg, pp 161\u2013333"},{"key":"42_CR15","first-page":"97","volume":"88","author":"VA Krasov","year":"1988","unstructured":"Krasov VA (1988) Sydnocarb treatment of young schoolchildren with hyperdynamic syndrome. Zh Nevropatol Psikhiatr Im S S Korsakova 88:97\u2013101 (in Russian)","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"},{"key":"42_CR16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.chi.0000222788.34229.68","volume":"45","author":"CJ Kratochvil","year":"2006","unstructured":"Kratochvil CJ, Wilens TE, Greenhill LL et al (2006) Effects of long-term atomoxetine treatment for young children with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:919\u2013927","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"42_CR17","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1542\/peds.108.5.e83","volume":"108","author":"D Michelson","year":"2001","unstructured":"Michelson D, Faries D, Wernike J et al (2001) Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose\u2013response study. Pediatrics 108:E83","journal-title":"Pediatrics"},{"key":"42_CR18","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","volume":"159","author":"D Michelson","year":"2002","unstructured":"Michelson D, Allen AJ, Busner J et al (2002) Once-daily atomoxetine treatment for children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159:1896\u20131901","journal-title":"Am J Psychiatry"},{"key":"42_CR19","unstructured":"Newcorn J, Allen AJ, Sutton V et al (2003) Characteristics of placebo responders in pediatric ADHD clinical trials. Paper presented at the 50th annual meeting of the American academy of child and adolescent psychiatry. Miami, FL"},{"key":"42_CR20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004583-200503000-00008","volume":"44","author":"HJ Newcorn","year":"2005","unstructured":"Newcorn HJ, Spencer TJ, Biederman J, Milton DR, Michelson D (2005) Atomoxetine treatment in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry 44:240\u2013248","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"42_CR21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","volume":"165","author":"HJ Newcorn","year":"2008","unstructured":"Newcorn HJ, Kratochwill CJ, Allen AJ et al (2008) Atomoxetine and osmotically released methylphenidate for the treatment of attention-deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 165:721\u2013730","journal-title":"Am J Psychiatry"},{"key":"42_CR22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1017\/S1360641701002507","volume":"6","author":"ED Palmer","year":"2001","unstructured":"Palmer ED, Finger S (2001) An early description of ADHD (inattentive subtype): Dr Alexander Crichton and \u201cmental restlessness\u201d (1798). Child Psychol Psychiatry Review 6:66\u201373","journal-title":"Child Psychol Psychiatry Review"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","volume":"164","author":"G Polanczyk","year":"2007","unstructured":"Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and meta-regression analysis. Am J Psychiatry 164:942\u2013948","journal-title":"Am J Psychiatry"},{"key":"42_CR24","unstructured":"Still GF (1902) The Culostian lectures on some abnormal psychical conditions in children. Lancet i1008\u2013i1012"},{"key":"42_CR25","volume-title":"Mental deficiency (amentia)","author":"AF Tredgold","year":"1908","unstructured":"Tredgold AF (1908) Mental deficiency (amentia). Tindall and Cox, Bailliere"},{"key":"42_CR26","volume-title":"COSTART: coding symbols of thesaurus of adverse reaction terms","author":"US Department of Health and Human Services","year":"1995","unstructured":"US Department of Health and Human Services (1995) COSTART: coding symbols of thesaurus of adverse reaction terms, 5th edn. US Food and Drug Administration, Rockville, MD","edition":"5"},{"key":"42_CR27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hup.513","volume":"18","author":"MG Uzbekov","year":"2003","unstructured":"Uzbekov MG, Misionzhnik EY (2003) Changes in urinary monoamine excretion in hyperkinetic children. Hum Psychopharmacol 18:493\u2013497","journal-title":"Hum Psychopharmacol"},{"key":"42_CR28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.chi.0000163280.47221.c9","volume":"44","author":"M Weiss","year":"2005","unstructured":"Weiss M, Tannock R, Kratochvil C et al (2005) A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 44:647\u2013655","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"42_CR29","unstructured":"Zavadenko N, Suvorinova N (1999) ADHD: study of motor control, attention, memory and experience with nootropics. In: Evrard Ph, Richelme Ch, Tardieu M (eds) Proceedings of the 3rd European paediatric neurology (EPNS) congress, Bologna, Monduzzi Editore, pp 81\u201385"},{"issue":"1","key":"42_CR30","first-page":"57","volume":"97","author":"NN Zavadenko","year":"1997","unstructured":"Zavadenko NN, TIu Uspenskaia, NIu Suvorinova (1997) The diagnosis and treatment of the attention-deficit syndrome in children. Zh Nevropatol Psikhiatr Im S S Korsakova 97(1):57\u201361","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"},{"key":"42_CR31","first-page":"675","volume-title":"New developments in child neurology","author":"N Zavadenko","year":"1998","unstructured":"Zavadenko N, Petrukhin A, Suvorinova N, Grigorieva N (1998) ADHD: study of prevalence, aetiology and efficiency of nootropics therapy. In: Velickovic Perat M (ed) New developments in child neurology. Monduzzi Editore, Bologna, pp 675\u2013679"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-009-0042-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-009-0042-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-009-0042-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T17:02:54Z","timestamp":1685034174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-009-0042-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s00787-009-0042-7","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,1]]}}}